$2.33 Million is the total value of Artal Group S.A.'s 105 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 30.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CAVA GROUP INC | $980,405 | -25.2% | 32,007,990 | 0.0% | 42.04% | +3.5% | ||
LXRX | LEXICON PHARMACEUTICALS INC | $128,133 | -52.4% | 117,553,284 | 0.0% | 5.49% | -34.1% | |
MRTX | Sell | MIRATI THERAPEUTICS INC | $88,175 | +18.7% | 2,024,226 | -1.5% | 3.78% | +64.3% |
BGNE | Sell | BEIGENE LTDsponsored adr | $72,656 | -1.2% | 403,934 | -2.1% | 3.12% | +36.7% |
RVMD | Buy | REVOLUTION MEDICINES INC | $70,023 | +9.0% | 2,529,737 | +5.3% | 3.00% | +50.8% |
SRRK | SCHOLAR ROCK HLDG CORP | $64,322 | -5.8% | 9,059,507 | 0.0% | 2.76% | +30.3% | |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $63,320 | -33.8% | 1,664,572 | +58.5% | 2.72% | -8.4% |
FOLD | Sell | AMICUS THERAPEUTICS INC | $49,401 | -13.8% | 4,062,567 | -11.0% | 2.12% | +19.3% |
MORF | Sell | MORPHIC HLDG INC | $48,986 | -60.1% | 2,138,188 | -0.1% | 2.10% | -44.8% |
CYTK | Buy | CYTOKINETICS INC | $44,745 | -3.1% | 1,518,831 | +7.3% | 1.92% | +34.0% |
SWTX | SPRINGWORKS THERAPEUTICS INC | $42,000 | -11.8% | 1,816,620 | 0.0% | 1.80% | +22.0% | |
New | NEUMORA THERAPEUTICS INC | $39,546 | – | 2,802,702 | +100.0% | 1.70% | – | |
CERE | CEREVEL THERAPEUTICS HLDNG I | $35,776 | -31.3% | 1,638,858 | 0.0% | 1.53% | -5.0% | |
MRTX | Buy | MIRATI THERAPEUTICS INCcall | $30,492 | +237.6% | 700,000 | +180.0% | 1.31% | +366.8% |
Buy | ACELYRIN INC | $25,113 | -34.0% | 2,469,279 | +35.6% | 1.08% | -8.7% | |
KYMR | KYMERA THERAPEUTICS INC | $25,094 | -39.5% | 1,805,346 | 0.0% | 1.08% | -16.3% | |
SLN | Buy | SILENCE THERAPEUTICS PLCads | $24,550 | +162.6% | 2,500,000 | +47.1% | 1.05% | +263.1% |
IMGN | Buy | IMMUNOGEN INC | $23,997 | +66.1% | 1,512,113 | +97.5% | 1.03% | +129.7% |
IGMS | IGM BIOSCIENCES INC | $21,061 | -9.5% | 2,522,244 | 0.0% | 0.90% | +25.2% | |
KURA | KURA ONCOLOGY INC | $18,405 | -13.8% | 2,018,056 | 0.0% | 0.79% | +19.2% | |
AGEN | AGENUS INC | $17,663 | -29.4% | 15,631,235 | 0.0% | 0.76% | -2.3% | |
SE | Buy | SEA LTDsponsored ads | $17,448 | -14.1% | 397,000 | +13.4% | 0.75% | +18.7% |
DNLI | DENALI THERAPEUTICS INC | $16,564 | -30.1% | 802,899 | 0.0% | 0.71% | -3.3% | |
ALVR | ALLOVIR INC | $14,184 | -36.8% | 6,597,167 | 0.0% | 0.61% | -12.5% | |
SDGR | Sell | SCHRODINGER INC | $14,135 | -59.5% | 500,000 | -28.6% | 0.61% | -44.0% |
Sell | VENTYX BIOSCIENCES INC | $14,074 | +5.0% | 405,239 | -0.8% | 0.60% | +45.3% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $13,660 | +11.4% | 1,193,030 | 0.0% | 0.59% | +54.2% | |
GLYC | GLYCOMIMETICS INC | $12,884 | -13.8% | 8,589,064 | 0.0% | 0.55% | +19.2% | |
New | RAYZEBIO INC | $12,333 | – | 555,556 | +100.0% | 0.53% | – | |
GERN | GERON CORP | $11,800 | -34.0% | 5,565,889 | 0.0% | 0.51% | -8.7% | |
Sell | ROIVANT SCIENCES LTD | $11,680 | -28.7% | 1,000,000 | -38.5% | 0.50% | -1.4% | |
TSHA | Buy | TAYSHA GENE THERAPIES INC | $11,575 | +1115.9% | 3,663,104 | +154.2% | 0.50% | +1553.3% |
WVE | Sell | WAVE LIFE SCIENCES LTD | $11,500 | +10.1% | 2,000,000 | -30.3% | 0.49% | +52.2% |
GBIO | GENERATION BIO CO | $10,666 | -31.1% | 2,814,191 | 0.0% | 0.46% | -4.8% | |
SEER | SEER INC | $10,498 | -48.2% | 4,750,000 | 0.0% | 0.45% | -28.5% | |
Sell | VIGIL NEUROSCIENCE INC | $10,285 | -42.7% | 1,908,135 | -0.2% | 0.44% | -20.8% | |
SELB | SELECTA BIOSCIENCES INC | $9,685 | -5.4% | 9,136,635 | 0.0% | 0.42% | +30.9% | |
OVID | OVID THERAPEUTICS INC | $9,600 | +17.1% | 2,500,000 | 0.0% | 0.41% | +62.2% | |
ERASCA INC | $9,301 | -28.6% | 4,721,194 | 0.0% | 0.40% | -1.2% | ||
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $8,925 | +108.1% | 102,699 | +141.6% | 0.38% | +188.0% |
NTRA | NATERA INC | $8,850 | -9.1% | 200,000 | 0.0% | 0.38% | +25.5% | |
NBTX | NANOBIOTIXsponsored ads | $8,750 | +72.6% | 1,000,000 | 0.0% | 0.38% | +138.9% | |
NTLA | INTELLIA THERAPEUTICS INC | $8,730 | -22.5% | 276,077 | 0.0% | 0.37% | +7.2% | |
FHTX | FOGHORN THERAPEUTICS INC | $8,604 | -29.0% | 1,720,720 | 0.0% | 0.37% | -1.6% | |
REPL | REPLIMUNE GROUP INC | $8,555 | -26.3% | 500,000 | 0.0% | 0.37% | +1.9% | |
RPTX | REPARE THERAPEUTICS INC | $8,456 | +14.2% | 700,000 | 0.0% | 0.36% | +57.8% | |
New | SAGIMET BIOSCIENCES INC | $8,138 | – | 924,771 | +100.0% | 0.35% | – | |
IKNA | IKENA ONCOLOGY INC | $8,008 | -34.0% | 1,849,513 | 0.0% | 0.34% | -8.8% | |
AUPH | AURINIA PHARMACEUTICALS INC | $7,770 | -19.7% | 1,000,000 | 0.0% | 0.33% | +11.0% | |
VRDN | VIRIDIAN THERAPEUTICS INC | $7,746 | -35.5% | 504,978 | 0.0% | 0.33% | -10.8% | |
DYN | DYNE THERAPEUTICS INC | $7,303 | -20.4% | 815,085 | 0.0% | 0.31% | +10.2% | |
DAWN | DAY ONE BIOPHARMACEUTICALS I | $6,135 | +2.8% | 500,000 | 0.0% | 0.26% | +42.2% | |
FOLD | AMICUS THERAPEUTICS INCcall | $6,080 | -3.2% | 500,000 | 0.0% | 0.26% | +33.8% | |
BDTX | BLACK DIAMOND THERAPEUTICS I | $5,874 | -43.2% | 2,046,517 | 0.0% | 0.25% | -21.2% | |
SYROS PHARMACEUTICALS INC | $5,829 | +25.4% | 1,475,744 | 0.0% | 0.25% | +73.6% | ||
VOR | VOR BIOPHARMA INC | $5,699 | -31.4% | 2,688,015 | 0.0% | 0.24% | -5.1% | |
OMEGA THERAPEUTICS INC | $5,446 | -61.6% | 2,533,045 | 0.0% | 0.23% | -47.0% | ||
GOSS | Buy | GOSSAMER BIO INC | $5,330 | +46.7% | 6,399,819 | +111.3% | 0.23% | +102.7% |
FUSN | FUSION PHARMACEUTICALS INC | $4,485 | -44.3% | 1,725,000 | 0.0% | 0.19% | -23.2% | |
ITOS | ITEOS THERAPEUTICS INC | $4,380 | -17.3% | 400,000 | 0.0% | 0.19% | +14.6% | |
BEKE | Sell | KE HLDGS INCsponsored ads | $4,268 | -17.9% | 275,000 | -21.4% | 0.18% | +13.7% |
VERV | VERVE THERAPEUTICS INC | $3,978 | -29.3% | 300,000 | 0.0% | 0.17% | -1.7% | |
HOOK | HOOKIPA PHARMA INC | $3,491 | -30.0% | 5,666,410 | 0.0% | 0.15% | -3.2% | |
BZ | KANZHUN LIMITEDsponsored ads | $3,337 | +0.8% | 220,000 | 0.0% | 0.14% | +38.8% | |
TALS | TALARIS THERAPEUTICS INC | $2,569 | -7.6% | 914,262 | 0.0% | 0.11% | +27.9% | |
SOLID BIOSCIENCES INC | $2,291 | -51.9% | 909,219 | 0.0% | 0.10% | -33.8% | ||
ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $2,052 | -3.8% | 2,255,375 | 0.0% | 0.09% | +33.3% | |
KRON | KRONOS BIO INC | $2,006 | -24.4% | 1,542,954 | 0.0% | 0.09% | +4.9% | |
RNA | AVIDITY BIOSCIENCES INC | $1,914 | -42.5% | 300,000 | 0.0% | 0.08% | -20.4% | |
PYPL | New | PAYPAL HLDGS INCcall | $1,871 | – | 32,000 | +100.0% | 0.08% | – |
V | VISA INC | $1,725 | -3.1% | 7,500 | 0.0% | 0.07% | +34.5% | |
MSFT | Buy | MICROSOFT CORP | $1,737 | +70.0% | 5,500 | +83.3% | 0.07% | +131.2% |
ADAG | ADAGENE INCads | $1,530 | +3.4% | 1,000,000 | 0.0% | 0.07% | +43.5% | |
AMZN | Buy | AMAZON COM INC | $1,525 | +16.9% | 12,000 | +20.0% | 0.06% | +62.5% |
IMAB | I MABsponsored ads | $1,122 | -55.9% | 850,000 | 0.0% | 0.05% | -39.2% | |
IRWD | IRONWOOD PHARMACEUTICALS INC | $1,064 | -9.5% | 110,532 | 0.0% | 0.05% | +27.8% | |
DDOG | Buy | DATADOG INC | $1,048 | +113.0% | 11,500 | +130.0% | 0.04% | +200.0% |
XILIO THERAPEUTICS INC | $950 | -19.4% | 450,000 | 0.0% | 0.04% | +10.8% | ||
ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponsored adr | $884 | -15.7% | 1,133,775 | 0.0% | 0.04% | +15.2% | |
GOOGL | Buy | ALPHABET INCcap stk cl a | $720 | +50.3% | 5,500 | +37.5% | 0.03% | +106.7% |
New | CURIS INC | $692 | – | 105,000 | +100.0% | 0.03% | – | |
SQ | New | BLOCK INCcl a | $686 | – | 15,500 | +100.0% | 0.03% | – |
ME | 23ANDME HOLDING CO | $646 | -44.2% | 661,009 | 0.0% | 0.03% | -22.2% | |
AMD | ADVANCED MICRO DEVICES INC | $617 | -9.7% | 6,000 | 0.0% | 0.03% | +23.8% | |
CARIBOU BIOSCIENCES INC | $504 | +12.5% | 105,347 | 0.0% | 0.02% | +57.1% | ||
NFLX | New | NETFLIX INC | $485 | – | 1,285 | +100.0% | 0.02% | – |
CYCLERION THERAPEUTICS INC | $473 | -17.0% | 138,403 | 0.0% | 0.02% | +11.1% | ||
New | HARPOON THERAPEUTICS INC | $403 | – | 100,000 | +100.0% | 0.02% | – | |
INTA | New | INTAPP INC | $335 | – | 10,000 | +100.0% | 0.01% | – |
CRWD | Sell | CROWDSTRIKE HLDGS INCcl a | $335 | -34.8% | 2,000 | -42.9% | 0.01% | -12.5% |
PEGA | New | PEGASYSTEMS INC | $326 | – | 7,500 | +100.0% | 0.01% | – |
PYPL | New | PAYPAL HLDGS INC | $292 | – | 5,000 | +100.0% | 0.01% | – |
PCOR | PROCORE TECHNOLOGIES INC | $294 | +0.3% | 4,500 | 0.0% | 0.01% | +44.4% | |
LVTX | LAVA THERAPEUTICS NV | $294 | -27.6% | 200,000 | 0.0% | 0.01% | 0.0% | |
BEAM | BEAM THERAPEUTICS INC | $264 | -24.6% | 10,975 | 0.0% | 0.01% | 0.0% | |
HIPPO HLDGS INC | $191 | -51.9% | 24,000 | 0.0% | 0.01% | -33.3% | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | $166 | -6.7% | 936 | 0.0% | 0.01% | +16.7% | |
ARWR | ARROWHEAD PHARMACEUTICALS IN | $146 | -24.7% | 5,440 | 0.0% | 0.01% | 0.0% | |
SQZ | SQZ BIOTECHNOLOGIES CO | $129 | -70.3% | 1,606,309 | 0.0% | 0.01% | -53.8% | |
KINETA INC | $106 | +32.5% | 31,055 | 0.0% | 0.01% | +150.0% | ||
SENTI BIOSCIENCES INC | $23 | -34.3% | 55,555 | 0.0% | 0.00% | 0.0% | ||
PLRX | PLIANT THERAPEUTICS INC | $26 | -3.7% | 1,490 | 0.0% | 0.00% | 0.0% | |
Sell | MINK THERAPEUTICS INC | $2 | -99.6% | 1,916 | -99.2% | 0.00% | -100.0% | |
CYCN | CYCLERION THERAPEUTICS INC | $2 | 0.0% | 552 | 0.0% | 0.00% | – | |
CFG | Exit | CITIZENS FINL GROUP INC | $0 | – | -10,000 | -100.0% | -0.01% | – |
Exit | STERLING CHECK CORP | $0 | – | -25,000 | -100.0% | -0.01% | – | |
KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -125,000 | -100.0% | -0.01% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -5,028 | -100.0% | -0.01% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -2,971 | -100.0% | -0.02% | – |
HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.02% | – |
CRIS | Exit | CURIS INC | $0 | – | -1,300,000 | -100.0% | -0.03% | – |
CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.04% | – |
SANA | Exit | SANA BIOTECHNOLOGY INC | $0 | – | -400,000 | -100.0% | -0.07% | – |
STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.08% | – |
CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -250,000 | -100.0% | -0.08% | – |
Exit | LUCID GROUP INC | $0 | – | -490,000 | -100.0% | -0.10% | – | |
ALXO | Exit | ALX ONCOLOGY HLDGS INC | $0 | – | -500,000 | -100.0% | -0.12% | – |
Exit | PORTAGE FINTECH ACQUISITN CO | $0 | – | -380,000 | -100.0% | -0.12% | – | |
MORF | Exit | MORPHIC HLDG INCcall | $0 | – | -100,000 | -100.0% | -0.18% | – |
ARAV | Exit | ARAVIVE INC | $0 | – | -4,572,515 | -100.0% | -0.18% | – |
MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -3,029,555 | -100.0% | -0.31% | – |
DHR | Exit | DANAHER CORPORATION | $0 | – | -47,500 | -100.0% | -0.35% | – |
AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -702,291 | -100.0% | -0.36% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.43% | – |
RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -1,213,725 | -100.0% | -0.47% | – |
Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -400,000 | -100.0% | -0.63% | – | |
SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.73% | – |
KRYS | Exit | KRYSTAL BIOTECH INC | $0 | – | -349,669 | -100.0% | -1.27% | – |
XBI | Exit | SPDR SER TRcall | $0 | – | -1,000,000 | -100.0% | -2.58% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AGENUS INC | 42 | Q3 2023 | 1.9% |
IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
BEIGENE LTD | 28 | Q3 2023 | 7.4% |
BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-25 |
4 | 2024-03-13 |
4 | 2024-02-29 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-13 |
4 | 2023-10-16 |
13F-HR | 2023-08-11 |
4 | 2023-06-22 |
3 | 2023-06-15 |
4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.